Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, with standard site chrome around it, indicating restricted access rather than the study content.
    Difference
    21%
    Check dated 2026-09-20T19:55:25.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    NIH grant year notes for 2016 and 2023 were added. The page revision label was updated to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-30T21:57:47.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Data-sharing and sponsor sections were added, including an IPD Sharing URL and IPD Plan Description. A PDF link for the Study Protocol and SAP was included, and PubMed references with MeSH terms were updated to provide broader context.
    Difference
    67%
    Check dated 2026-08-16T17:06:11.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor backend/documentation update to the study record.
    Difference
    0.0%
    Check dated 2026-08-09T11:51:53.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a software/version update to the site rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-07-25T18:34:22.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous v3.6.2, indicating an updated page build. This reflects an internal update or bug fix rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-07-04T05:09:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.